Skip to main content
. 2016 May 18;7(29):46636–46645. doi: 10.18632/oncotarget.9432

Table 2. Estimates of BCSS and OS and pairwise comparisons according to tumor size and lymph node status.

Tumor size/nodal status No. of patients BCSS OS
No. of events Overall Pa Pairwise Adjusted Pb No. of events Overall Pa Pairwise Adjusted Pb
Total 10771 337 <0.001 N0 v N1 0.133 547 <0.001 N0 v N1 0.011
N0 7481 115 N0 v N2 0.654 234 N0 v N2 0.785
N1 2355 130 N0 v N3 0.377 177 N0 v N3 0.999
N2 562 38 N1 v N2 1.000 63 N1 v N2 0.916
N3 373 54 N1 v N3 0.002 73 N1 v N3 0.054
N2 v N3 0.053 N2 v N3 0.729
T1 <0.001 N0 v N1 0.984 <0.001 N0 v N1 0.114
Total 5292 76 N0 v N2 0.944 151 N0 v N2 0.999
N0 4343 37 N0 v N3 0.865 93 N0 v N3 1.000
N1 747 25 N1 v N2 0.998 35 N1 v N2 0.874
N2 130 6 N1 v N3 0.610 12 N1 v N3 0.836
N3 72 8 N2 v N3 0.592 11 N2 v N3 1.000
T2 <0.001 N0 v N1 0.138 <0.001 N0 v N1 0.248
Total 4640 178 N0 v N2 0.678 280 N0 v N2 0.963
N0 2825 62 N0 v N3 1.000 112 N0 v N3 1.000
N1 1294 75 N1 v N2 1.000 102 N1 v N2 0.986
N2 327 26 N1 v N3 0.542 39 N1 v N3 0.874
N3 194 15 N2 v N3 0.829 27 N2 v N3 0.999
T3 <0.001 N0 v N1 0.841 <0.001 N0 v N1 0.854
Total 839 83 N0 v N2 1.000 116 N0 v N2 0.931
N0 313 16 N0 v N3 0.987 29 N0 v N3 0.993
N1 314 30 N1 v N2 0.993 40 N1 v N2 1.000
N2 105 6 N1 v N3 0.190 12 N1 v N3 0.375
N3 107 31 N2 v N3 0.987 35 N2 v N3 0.670
a

Overall P was calculated using the Kaplan-Meier method and the log-rank test, and bold type indicates significance.

b

Adjusted P was calculated using Sidak pairwise comparisons, and bold type indicates significance.